Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weon Kim

Showing results (671-680 of 710) with videos related to

Pageof 71
Sort By:
The New England Journal of Medicine|September 2, 2022
Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCIBon-Kwon Koo, Xinyang Hu, Jeehoon Kang, et al.
The Lancet. Oncology|August 30, 2024
Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroupCarien L Creutzberg, Jae-Weon Kim, Gemma Eminowicz, et al.
JAMA Network Open|January 3, 2024
Physiology- or Imaging-Guided Strategies for Intermediate Coronary StenosisSeokhun Yang, Jeehoon Kang, Doyeon Hwang, et al.
Gynecologic Oncology|February 22, 2021
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committeeJean-Emmanuel Kurtz, Val Gebski, Vladyslav Sukhin, et al.
American Heart Journal|April 3, 2026
Optimal antiplatelet strategy in patients with advanced chronic kidney disease undergoing drug-eluting stent implantation: Design and rationale of the randomized ADAPT-CKD trialIn Tae Jin, Sang-Hyup Lee, Kyeong Ho Yun, et al.
Lancet (London, England)|December 4, 2019
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trialAndrew R Clamp, Elizabeth C James, Iain A McNeish, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 4, 2025
Fractional flow reserve- and intravascular ultrasound-guided strategies for intermediate coronary stenosis and low lesion complexity in patients with or without diabetes: a post hoc analysis of the randomised FLAVOUR trialSung Woo Cho, Jeehoon Kang, Jinlong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2025
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without <i>BRCA</i> MutationPanagiotis A Konstantinopoulos, Jae Weon Kim, Gilles Freyer, et al.
Hypertension (Dallas, Tex. : 1979)|February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCTJeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.
JACC. Asia|January 31, 2025
Prognostic Value of Postpercutaneous Coronary Intervention Murray-Law-Based Quantitative Flow Ratio: Post Hoc Analysis From FLAVOUR TrialDaixin Ding, Jinlong Zhang, Peng Wu, et al.
Pageof 71

Showing results (671-680 of 710) with videos related to

Sort By:
Pageof 71
The New England Journal of Medicine|September 2, 2022
Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCIBon-Kwon Koo, Xinyang Hu, Jeehoon Kang, et al.
The Lancet. Oncology|August 30, 2024
Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroupCarien L Creutzberg, Jae-Weon Kim, Gemma Eminowicz, et al.
JAMA Network Open|January 3, 2024
Physiology- or Imaging-Guided Strategies for Intermediate Coronary StenosisSeokhun Yang, Jeehoon Kang, Doyeon Hwang, et al.
Gynecologic Oncology|February 22, 2021
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committeeJean-Emmanuel Kurtz, Val Gebski, Vladyslav Sukhin, et al.
American Heart Journal|April 3, 2026
Optimal antiplatelet strategy in patients with advanced chronic kidney disease undergoing drug-eluting stent implantation: Design and rationale of the randomized ADAPT-CKD trialIn Tae Jin, Sang-Hyup Lee, Kyeong Ho Yun, et al.
Lancet (London, England)|December 4, 2019
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trialAndrew R Clamp, Elizabeth C James, Iain A McNeish, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 4, 2025
Fractional flow reserve- and intravascular ultrasound-guided strategies for intermediate coronary stenosis and low lesion complexity in patients with or without diabetes: a post hoc analysis of the randomised FLAVOUR trialSung Woo Cho, Jeehoon Kang, Jinlong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2025
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without <i>BRCA</i> MutationPanagiotis A Konstantinopoulos, Jae Weon Kim, Gilles Freyer, et al.
Hypertension (Dallas, Tex. : 1979)|February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCTJeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.
JACC. Asia|January 31, 2025
Prognostic Value of Postpercutaneous Coronary Intervention Murray-Law-Based Quantitative Flow Ratio: Post Hoc Analysis From FLAVOUR TrialDaixin Ding, Jinlong Zhang, Peng Wu, et al.
Pageof 71